Company · CIK 0001770121 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Sana Biotechnology, Inc. · SANA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 FMForm 4 → | Aug 27, 4:21 pm EDT | Dhavalkumar Dhirajlal PatelEVP, Chief Scientific Officer | 166,158 | $4.11 | $169,159 | 183,352 | — | |
| Jul 6, 2026 AForm 4 → | Jul 7, 4:31 pm EDT | Hans Edgar BishopDirector | 6,297 | — | — | 5,854,800 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 MForm 4 → | Aug 27, 4:21 pm EDT | Dhavalkumar Dhirajlal PatelEVP, Chief Scientific Officer | 125,000 | — | — | 250,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:43 pm EDT | Patrick Y YangDirector | 90,000 | — | — | 90,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:41 pm EDT | Robert L. RosielloDirector | 90,000 | — | — | 90,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:39 pm EDT | Michelle SeitzDirector | 90,000 | — | — | 90,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:38 pm EDT | Alise ReicinDirector | 90,000 | — | — | 90,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:36 pm EDT | Richard MulliganDirector | 90,000 | — | — | 90,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:34 pm EDT | Hans Edgar BishopDirector | 90,000 | — | — | 90,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:32 pm EDT | Joshua H. BilenkerDirector | 90,000 | — | — | 90,000 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:25 pm EDT | Robert NelsenDirector, 10% Owner | 90,000 | — | — | 90,000 | — |